Literature DB >> 24756035

Mini-cognitive testing in patients with age-related macular degeneration.

Khalil M Al-Salem1, Shlomit Schaal.   

Abstract

PURPOSE: To compare Mini-Cognitive (Mini-Cog) Screening test results between patients with age-related macular degeneration (AMD) and age-matched controls. PARTICIPANTS: Two hundred and twenty-nine patients were included in the study. Patients were divided into 3 groups: 56 patients with exudative AMD, mean age of 76 ± 8 years; 82 patients with dry AMD, mean age of 77 ± 9 years; and 91 controls, mean age of 75 ± 8 years.
METHODS: The Mini-Cog test, used to screen patients with early cognitive impairment, was introduced to the three groups of patients at the settings of an ophthalmology outpatient clinic. Test scores were compared between the groups.
RESULTS: The mean for the Mini-Cog test scores was 3.5 (95% confidence interval, 3.15-3.85) for the dry AMD group, 3.95 (95% confidence interval, 3.51-4.39) for the exudative AMD group, and 4.63 (95% confidence interval, 4.45-4.80) for the control group. There was no statistically significant difference between the scores of AMD groups, however, both AMD groups received significantly lower scores than controls (P < 0.0001).
CONCLUSION: Patients with age-related macular degeneration in this study demonstrated lower mean scores in the Mini-Cog test than age-matched controls. The Mini-Cog test may be easily applied at an office setting of ophthalmology outpatient clinics, and may help in the early diagnosis of cognitive impairment in the patients with AMD.

Entities:  

Mesh:

Year:  2014        PMID: 24756035     DOI: 10.1097/IAE.0000000000000006

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

1.  Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease.

Authors:  Cecilia S Lee; Eric B Larson; Laura E Gibbons; Aaron Y Lee; Susan M McCurry; James D Bowen; Wayne C McCormick; Paul K Crane
Journal:  Alzheimers Dement       Date:  2018-08-08       Impact factor: 21.566

2.  Lower cognitive function in patients with age-related macular degeneration: a meta-analysis.

Authors:  Li-Xiao Zhou; Cheng-Lin Sun; Li-Juan Wei; Zhi-Min Gu; Liang Lv; Yalong Dang
Journal:  Clin Interv Aging       Date:  2016-02-24       Impact factor: 4.458

3.  Increased risk of Parkinson's disease among patients with age-related macular degeneration.

Authors:  Po-Yu Jay Chen; Lei Wan; Jung-Nien Lai; Chih Sheng Chen; Jamie Jiin-Yi Chen; Wu Ming Yen; Lu-Ting Chiu; Kai-Chieh Hu; Peng-Tai Tien; Hui-Ju Lin
Journal:  BMC Ophthalmol       Date:  2021-12-09       Impact factor: 2.209

Review 4.  Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis.

Authors:  Cecilia Czakó; Tibor Kovács; Zoltan Ungvari; Anna Csiszar; Andriy Yabluchanskiy; Shannon Conley; Tamas Csipo; Agnes Lipecz; Hajnalka Horváth; Gábor László Sándor; Lilla István; Trevor Logan; Zoltán Zsolt Nagy; Illés Kovács
Journal:  Geroscience       Date:  2020-10-04       Impact factor: 7.713

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.